Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer

被引：25
|
作者：
Wei, Yuanyuan [1 ,2 ]
Zhu, Mengyu [1 ]
Schober, Andreas [1 ,2 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, Expt Vasc Med, D-80336 Munich, Germany
[2] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, D-80802 Munich, Germany
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2018年 / 19卷 / 06期
关键词：
immune disorders; microRNA; macrophage; lipid metabolism; chronic inflammation; TUMOR-ASSOCIATED MACROPHAGES; NF-KAPPA-B; ADIPOSE-TISSUE MACROPHAGES; COLONY-STIMULATING FACTOR; NITRIC-OXIDE SYNTHASE; PROMOTES ATHEROSCLEROSIS; ALTERNATIVE ACTIVATION; CHOLESTEROL EFFLUX; KETONE-BODIES; IMMUNE CELLS;
D O I：
10.3390/ijms19061756
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Macrophages play a crucial role in the innate immune system and contribute to a broad spectrum of pathologies in chronic inflammatory diseases. MicroRNAs (miRNAs) have been demonstrated to play important roles in macrophage functions by regulating macrophage polarization, lipid metabolism and so on. Thus, miRNAs represent promising diagnostic and therapeutic targets in immune disorders. In this review, we will summarize the role of miRNAs in atherosclerosis, metabolic syndrome, and cancer by modulating macrophage phenotypes, which has been supported by in vivo evidence.
引用
收藏
页数：20
相关论文
共 50 条
  • [31] MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets
    Hussein, Mohamed Ali
    Munirathinam, Gnanasekar
    CANCERS, 2023, 15 (20)
  • [32] MicroRNAs as Therapeutic Targets for Anticancer Drugs in Lung Cancer Therapy
    Liu, Yuan-Rong
    Wang, Ping-Yu
    Xie, Ning
    Xie, Shu-Yang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (16) : 1883 - 1894
  • [33] MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
    Stiegelbauer, Verena
    Perakis, Samantha
    Deutsch, Alexander
    Ling, Hui
    Gerger, Armin
    Pichler, Martin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (33) : 11727 - 11735
  • [34] Nuclear receptors as therapeutic targets to modulate the metabolic syndrome
    Staels, B.
    FEBS JOURNAL, 2006, 273 : 20 - 20
  • [35] Nuclear receptors as therapeutic targets to modulate the metabolic syndrome
    Staels, B.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2006, 143 (1-2) : 47 - 47
  • [36] Crosstalk between macrophage and T cell in atherosclerosis: Potential therapeutic targets for cardiovascular diseases
    Song, Meiying
    Xu, Shixin
    Zhong, Aiqin
    Zhang, Junping
    CLINICAL IMMUNOLOGY, 2019, 202 : 11 - 17
  • [37] Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis
    Choudhury, RP
    Lee, JM
    Greaves, DR
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (06): : 309 - 315
  • [38] Mechanisms of Disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis
    Robin P Choudhury
    Justin M Lee
    David R Greaves
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 309 - 315
  • [39] CHEMOKINES AS THERAPEUTIC TARGETS IN ATHEROSCLEROSIS
    Weber, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [40] Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy
    Fendl, B.
    Berghoff, A. S.
    Preusser, M.
    Maier, B.
    ESMO OPEN, 2023, 8 (01)
12345